Background: Radiochemical purity is a key criterion for the quality of radiopharmaceuticals used in clinical practice. The joint improvement of analytical methods capable of identifying related radiochemical impurities and determining the actual radiochemical purity, as well as the improvement of synthesis methods to minimize the formation of possible radiochemical impurities, is integral to the implementation of high-tech nuclear medicine procedures. PSMA-targeted radionuclide therapy with lutetium-177 has emerged as an effective treatment option for prostate cancer, and [Lu]Lu-PSMA-617 and [Lu]Lu-PSMA have achieved global recognition as viable radiopharmaceuticals.
View Article and Find Full Text PDFThe data from two Bulgarian-German instruments with the basic name "Radiation Risk Radiometer-Dosimeter" (R3D) are discussed. The R3DR instrument worked inside the ESA EXPOSE-R facility (2009-2010), while R3DR2 worked inside the ESA EXPOSE-R2 facility (2014-2016). Both were outside the Russian Zvezda module on the International Space Station (ISS).
View Article and Find Full Text PDFThe knowledge of the space radiation environment in spacecraft transition and in Mars vicinity is of importance for the preparation of the human exploration of Mars. ExoMars Trace Gas Orbiter (TGO) was launched on March 14, 2016 and was inserted into circular Mars science orbit (MSO) with a 400 km altitude in March 2018. The Liulin-MO dosimeter is a module of the Fine Resolution Epithermal Neutron Detector (FREND) aboard ExoMars TGO and has been measuring the radiation environment during the TGO interplanetary travel to Mars and continues to do so in the TGO MSO.
View Article and Find Full Text PDFThe dosimeter Liulin-MO for measuring the radiation environment onboard the ExoMars Trace Gas Orbiter (TGO) is a module of the Fine Resolution Epithermal Neutron Detector (FREND). Here we present results from measurements of the charged particle fluxes, dose rates and estimation of dose equivalent rates at ExoMars TGO Mars science orbit, provided by Liulin-MO from May 2018 to June 2022. The period of measurements covers the declining and minimum phases of the solar activity in 24th solar cycle and the rising phase of the 25th cycle.
View Article and Find Full Text PDFThe radiolytic degradation of vector molecules is a major factor affecting the shelf life of therapeutic radiopharmaceuticals. The development of time-stable dosage forms of radiopharmaceuticals is the key to their successful implementation in clinical practice. Using [Lu]Lu-PSMA-617 molecule as an example, the time dependence of the change in radiochemical purity (RCP, %) under radiolysis conditions was studied.
View Article and Find Full Text PDF